The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 06, 2015

Filed:

Jan. 29, 2013
Applicant:

Pfizer Limited, Sandwich, Kent, GB;

Inventors:

Sharanjeet Kaur Bagal, Great Abington, GB;

Alan Daniel Brown, Great Abington, GB;

Mark Ian Kemp, Sandwich, GB;

Wolfgang Klute, Sandwich, GB;

Laia Malet Sanz, Sandwich, GB;

Brian Edward Marron, Durham, NC (US);

Duncan Charles Miller, Sandwich, GB;

Sarah Elizabeth Skerratt, Great Abington, GB;

Mark J. Suto, Birmingham, AL (US);

Christopher William West, Durham, NC (US);

Assignee:

Pfizer LImited, Sandwich, Kent, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4184 (2006.01); C07D 235/04 (2006.01); C07D 233/64 (2006.01); C07D 401/04 (2006.01); A61K 45/06 (2006.01); A61K 31/437 (2006.01); C07D 235/14 (2006.01); C07D 403/04 (2006.01); A61K 31/454 (2006.01); C07D 235/16 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4184 (2013.01); C07D 233/64 (2013.01); C07D 401/04 (2013.01); A61K 45/06 (2013.01); A61K 31/437 (2013.01); C07D 235/14 (2013.01); C07D 403/04 (2013.01); A61K 31/454 (2013.01); C07D 235/16 (2013.01); C07D 471/04 (2013.01);
Abstract

The invention relates to benzimidazole and imidazopyridine derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to new Na1.8 modulators of formula (I) or pharmaceutically acceptable salts thereof, wherein R, R, R, R, R, R, R. X and Y are as defined in the description. Na1.8 modulators are potentially useful in the treatment of a wide range of disorders, particularly pain.


Find Patent Forward Citations

Loading…